DR.NOAH BIOTECH
Latest round
- Series B
Last raised
- Jun 2022
Total raised
- $15M
Investors
- 10
About DR.NOAH BIOTECH
Based in South Korea, Dr.Founded in 2016, Dr. Noah Biotech operates out of Suwon, South Korea and is dedicated to advancing drug development for orphan diseases through its innovative AI-driven platforms.Dr. Noah Biotech specializes in the development of innovative drug candidates, particularly focusing on complex drug combinations aimed at treating orphan diseases. Their core offerings include an AI-based platform known as the ARK system, which comprises multiple solutions for drug repositioning and synergistic combination therapies. The platform leverages extensive bio-pharmacological data to identify potential drug candidates, reducing clinical trial failure rates related to safety and efficacy. The company collaborates with global partners across diverse geographical markets, including North America and Europe, to enhance its research and development capabilities.Dr. Noah Biotech generates revenue primarily through strategic partnerships and collaborations with international pharmaceutical companies and research institutions. The transaction structure typically involves B2B agreements, where the company provides its AI-driven drug discovery services in exchange for service fees or milestone payments tied to the development progress of drug candidates. These partnerships often include contracts that allow for revenue sharing based on the successful commercialization of developed therapies.In June 2022, Dr.S. and the upcoming pipelines of preclinical trials. The company plans to expand its market presence into additional regions, focusing on North America and Europe, with specific initiatives aimed for completion by 2024. Through these efforts, Dr. Noah Biotech aims to enhance its capabilities in drug development and better serve patients with orphan diseases.
Who invested in DR.NOAH BIOTECH
10 investors across 2 rounds
See all investors in DR.NOAH BIOTECH
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about DR.NOAH BIOTECH
Who invested in DR.NOAH BIOTECH?
DR.NOAH BIOTECH has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has DR.NOAH BIOTECH raised?
DR.NOAH BIOTECH has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did DR.NOAH BIOTECH last raise money?
DR.NOAH BIOTECH's most recent round on record is a Series B, in Jun 2022.
What does DR.NOAH BIOTECH do?
DR.NOAH BIOTECH is a biotechnology company.
Where is DR.NOAH BIOTECH headquartered?
DR.NOAH BIOTECH is headquartered in Suwon, South Korea.
Which VCs invest in companies like DR.NOAH BIOTECH?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at DR.NOAH BIOTECH's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like DR.NOAH BIOTECH? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.